Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/993000


Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015


Description: Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Brazil In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Brazil

Scope

- The report provides information on the Brazilian in vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., and Siemens Medical Solutions, amongst others.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in Brazil.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Contents: 1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.2.1 Clinical Chemistry Rapid Tests & POC
3.2.2 Clinical Chemisty Analyzers
3.2.2.1 Automated Clinical Chemistry Analyzers
3.2.2.2 Semi-Automated Clinical Chemistry Analyzers
3.2.3 Electrolyte Chemistry Reagents
3.2.4 Enzyme Chemistry Reagents
3.2.5 Metabolite Chemistry Reagents
3.2.6 Urine Analysis
3.2.6.1 Urine Analyzer Reagents
3.2.6.2 Urine Analyzers
3.3 Genetic Testing
3.3.1 Acquired Gene or Chromosome Alterations
3.3.2 Inborn Gene or Chromosome Alterations
3.3.3 Other Genetic Tests
3.4 Haematology
3.4.1 Haematology Analyzers
3.4.2 Haematology Cell Counters
3.4.2.1 Differential Counters
3.4.2.2 Hemoglobinometers
3.4.3 Haematology Rapid Tests
3.4.3.1 Haemostasis Rapid Tests (Home Monitoring)
3.4.3.2 Rapid Haematology Tests (Point-Of-Care/Near Patient)
3.4.4 Haematology Reagents
3.4.4.1 Haematology Analyzer Reagents
3.4.4.2 Slide Stainers
3.4.5 Haemostasis
3.4.5.1 Coagulation Analyzers
3.4.5.2 Coagulation Factors
3.4.5.3 General Coagulation Tests
3.4.5.4 Platelet Factors
3.4.5.5 Special Coagulation Tests
3.4.6 Immunohaematology
3.4.6.1 ABO Typing
3.4.6.2 Antibody Detection
3.4.6.3 Rhesus Typing
3.5 Histology And Cytology
3.5.1 Cytology
3.5.1.1 Flow Cytometers
3.5.2 Histology
3.5.2.1 Monoclonal Antibodies
3.5.2.2 Tissue Typing Reagents
3.6 Immuno Chemistry
3.6.1 Disease Specific Immunochemistry
3.6.1.1 Auto-Immune Diseases
3.6.1.2 Cardiac Markers
3.6.1.3 Rheumatoid - Inflammatory Diseases Markers
3.6.1.4 Tumor markers
3.6.2 Drug Related Testing
3.6.2.1 Drugs of Abuse / Toxicology
3.6.2.2 Therapeutic Drug Monitoring
3.6.3 Endocrinology Tests
3.6.3.1 Fertility or Pregnancy Hormones
3.6.3.2 Individual and Specified Hormones
3.6.3.3 Thyroid Function Hormones
3.6.4 Immunochemistry Analyzers
3.6.4.1 Chemiluminescence Analyzers
3.6.4.2 ELISA Instruments
3.6.4.3 Immunofluorescence Analyzers
3.6.4.4 Radioimmunoassay Analyzers
3.6.5 Immunochemistry Rapid Tests
3.6.6 Organ Function Assays
3.6.7 Specific Proteins
3.7 Infectious Immunology
3.7.1 Bacteriology
3.7.2 Hepatitis Viruses
3.7.3 Other Virology
3.7.4 Retroviruses
3.8 Microbiology Culture
3.8.1 Bacterial Identification & Susceptibility Testing
3.8.2 Blood Culture
3.8.3 Immunological Culture Identification
3.8.4 Microbiology Analyzers
3.8.4.1 Automated Microbiology Analyzers
3.8.4.2 Semi-Automated Microbiology Analyzers
3.8.5 Mycobacteria Culture
3.8.6 Mycology Culture
3.8.7 Parasitology Culture
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
5 Regulation System
5.1 Medical Device Registration Protocol
5.1.1 Registration Documentation
5.1.2 Registration Procedure
5.1.3 Used/ Refurbished Equipment Import Regulations
5.1.4 Healthcare Products Registration Fee
6 Pricing and Reimbursement
7 Distribution Structure
8 In Vitro Diagnostics In Brazil
8.1 In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015
8.2 In Vitro Diagnostics, Brazil, Company Share (2007-2008)
9 Clinical Chemistry In Brazil
9.1 Clinical Chemistry Overall Revenue (2000-2015)
9.1.1 Clinical Chemistry Analyzers Revenue (2000-2015)
9.1.2 Urine Analysis Revenue (2000-2015)
9.2 Clinical Chemistry Distribution Share (2007-2008)
9.3 Clinical Chemistry, Brazil, Company Share (2007-2008)
10 Genetic Testing In Brazil
10.1 Genetic Testing Overall Revenue (2000-2015)
10.2 Genetic Testing Distribution Share (2007-2008)
10.3 Genetic Testing, Brazil, Company Share (2007-2008)
11 Haematology In Brazil
11.1 Haematology Overall Revenue (2000-2015)
11.1.1 Haematology Reagents Revenue (2000-2015)
11.1.2 Immunohaematology Revenue (2000-2015)
11.1.3 Haemostasis Revenue (2000-2015)
11.1.4 Haematology Rapid Tests Revenue (2000-2015)
11.1.5 Haematology Cell Counters Revenue (2000-2015)
11.2 Haematology Distribution Share (2007-2008)
11.3 Haematology, Brazil, Company Share (2007-2008)
12 Histology and Cytology In Brazil
12.1 Histology and Cytology Overall Revenue (2000-2015)
12.1.1 Histology Revenue (2000-2015)
12.2 Histology And Cytology Distribution Share (2007-2008)
12.3 Histology And Cytology, Brazil, Company Share (2007-2008)
13 Immuno Chemistry In Brazil
13.1 Immuno Chemistry Overall Revenue (2000-2015)
13.1.1 Disease Specific Immunochemistry Revenue (2000-2015)
13.1.2 Drug Related Testing Revenue (2000-2015)
13.1.3 Endocrinology Tests Revenue (2000-2015)
13.1.4 Immunochemistry Analyzers Revenue (2000-2015)
13.2 Immuno Chemistry Distribution Share (2007-2008)
13.3 Immuno Chemistry, Brazil, Company Share (2007-2008)
14 Infectious Immunology In Brazil
14.1 Infectious Immunology Overall Revenue (2000-2015)
14.2 Infectious Immunology Distribution Share (2007-2008)
14.3 Infectious Immunology, Brazil, Company Share (2007-2008)
15 Microbiology Culture In Brazil
15.1 Microbiology Culture Overall Revenue (2000-2015)
15.1.1 Microbiology Analyzers Revenue (2000-2015)
15.2 Microbiology Culture Distribution Share (2007-2008)
15.3 Microbiology Culture, Brazil, Company Share (2007-2008)
16 Overview of Key Companies in Brazil In Vitro Diagnostics Market
16.1 Ventana Medical Systems, Inc.
16.1.1 Company Overview
16.2 Sysmex Corporation
16.2.1 Company Overview
16.2.2 Sysmex Corporation Pipeline Products
16.2.2.1 Sysmex Corporation Pipeline Products By Equipment Type
16.2.2.2 Sysmex Corporation Pipeline Products By Development Stage
16.2.2.3 Sysmex Corporation Pipeline Products By Therapy Area
16.2.2.4 Sysmex Corporation Pipeline Products By News Summary
16.3 Siemens Healthcare
16.3.1 Company Overview
16.4 Qiagen N.V.
16.4.1 Company Overview
16.4.2 Qiagen N.V. Pipeline Products
16.4.2.1 Qiagen N.V. Pipeline Products By Equipment Type
16.4.2.2 Qiagen N.V. Pipeline Products By Development Stage
16.4.2.3 Qiagen N.V. Pipeline Products By Therapy Area
16.4.2.4 Qiagen N.V. Pipeline Products By News Summary
16.5 Phadia AB
16.5.1 Company Overview
16.5.2 Phadia AB Pipeline Products
16.5.2.1 Phadia AB Pipeline Products By Equipment Type
16.5.2.2 Phadia AB Pipeline Products By Development Stage
16.5.2.3 Phadia AB Pipeline Products By Therapy Area
16.5.2.4 Phadia AB Pipeline Products By News Summary
16.6 Ortho-Clinical Diagnostics Inc.
16.6.1 Company Overview
16.6.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
16.6.2.1 Ortho-Clinical Diagnostics Inc. Pipeline Products By Equipment Type
16.6.2.2 Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
16.6.2.3 Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
16.7 OLYMPUS CORPORATION
16.7.1 Company Overview
16.8 Inverness Medical Innovations, Inc.
16.8.1 Company Overview
16.8.2 Inverness Medical Innovations, Inc. Pipeline Products
16.8.2.1 Inverness Medical Innovations, Inc. Pipeline Products By Equipment Type
16.8.2.2 Inverness Medical Innovations, Inc. Pipeline Products By Development Stage
16.8.2.3 Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area
16.8.2.4 Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials
16.8.2.5 Inverness Medical Innovations, Inc. Pipeline Products By News Summary
16.9 Hologic, Inc.
16.9.1 Company Overview
16.9.2 Hologic, Inc. Pipeline Products
16.9.2.1 Hologic, Inc. Pipeline Products By Equipment Type
16.9.2.2 Hologic, Inc. Pipeline Products By Development Stage
16.9.2.3 Hologic, Inc. Pipeline Products By Therapy Area
16.9.2.4 Hologic, Inc. Pipeline Products By Clinical Trials
16.9.2.5 Hologic, Inc. Pipeline Products By News Summary
16.10 Gen-Probe Incorporated
16.10.1 Company Overview
16.10.2 Gen-Probe Incorporated Pipeline Products
16.10.2.1 Gen-Probe Incorporated Pipeline Products By Equipment Type
16.10.2.2 Gen-Probe Incorporated Pipeline Products By Development Stage
16.10.2.3 Gen-Probe Incorporated Pipeline Products By Therapy Area
16.10.2.4 Gen-Probe Incorporated Pipeline Products By Clinical Trials
16.10.2.5 Gen-Probe Incorporated Pipeline Products By News Summary
16.11 F. Hoffmann-La Roche Ltd.
16.11.1 Company Overview
16.12 DiaSorin S.p.A
16.12.1 Company Overview
16.12.2 DiaSorin S.p.A Pipeline Products
16.12.2.1 DiaSorin S.p.A Pipeline Products By Equipment Type
16.12.2.2 DiaSorin S.p.A Pipeline Products By Development Stage
16.12.2.3 DiaSorin S.p.A Pipeline Products By Therapy Area
16.13 Dade Behring Holdings, Inc.
16.13.1 Company Overview
16.14 Bio-Rad Laboratories, Inc.
16.14.1 Company Overview
16.15 bioMerieux S.A.
16.15.1 Company Overview
16.16 Becton, Dickinson and Company
16.16.1 Company Overview
16.16.2 Becton, Dickinson and Company Pipeline Products
16.16.2.1 Becton, Dickinson and Company Pipeline Products By Equipment Type
16.16.2.2 Becton, Dickinson and Company Pipeline Products By Development Stage
16.16.2.3 Becton, Dickinson and Company Pipeline Products By Therapy Area
16.16.2.4 Becton, Dickinson and Company Pipeline Products By Clinical Trials
16.16.2.5 Becton, Dickinson and Company Pipeline Products By News Summary
16.17 Beckman Coulter, Inc.
16.17.1 Company Overview
16.17.2 Beckman Coulter, Inc. Pipeline Products
16.17.2.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type
16.17.2.2 Beckman Coulter, Inc. Pipeline Products By Development Stage
16.17.2.3 Beckman Coulter, Inc. Pipeline Products By Therapy Area
16.17.2.4 Beckman Coulter, Inc. Pipeline Products By News Summary
16.18 Abbott Laboratories
16.18.1 Company Overview
16.18.2 Abbott Laboratories Pipeline Products
16.18.2.1 Abbott Laboratories Pipeline Products By Equipment Type
16.18.2.2 Abbott Laboratories Pipeline Products By Development Stage
16.18.2.3 Abbott Laboratories Pipeline Products By Therapy Area
17 Financial Deals Landscape
17.1 Acquisition
17.1.1 Caio Auriemo Completes Sale Of Stake In Diagnosticos da America
17.1.2 FIR Capital Partners Sells Stake In Prodimol Biotecnologia To Orgenics
17.2 Partnerships
17.2.1 Chembio Signs An Agreement With Oswaldo Cruz Foundation
18 Recent Developments
18.1 Strategy And Business Planning
18.1.1 May 20, 2009: Moksha8, Roche Expands Alliance For Brazilian and Mexican Markets
18.2 Other Significant Developments
18.2.1 May 28, 2009: Qiagen To Supply Molecular Screening Solutions To Increase Safety Of Blood Donations In Brazil
19 Appendix
19.1 Global Markets Direct Research Methodology
19.2 Secondary Research
19.3 Primary Research
19.4 Models
19.5 Forecasts
19.6 Expert Panel Validation
19.7 Currency Conversion
19.8 Contact Us
19.9 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Health Expenditure in Brazil, 2000-2007 25
Table 2: Healthcare Products Registration Fee in Brazil, 2002 29
Table 3: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015 33
Table 4: In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-2015 34
Table 5: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Historic, 2000-2008 36
Table 6: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015 38
Table 7: In Vitro Diagnostics, Brazil, Company Share by Revenue ($ mn), 2007-2008 39
Table 8: Clinical Chemistry, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 41
Table 9: Clinical Chemistry, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 43
Table 10: Clinical Chemistry Analyzers, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 44
Table 11: Clinical Chemistry Analyzers, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 45
Table 12: Urine Analysis, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 46
Table 13: Urine Analysis, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 47
Table 14: Clinical Chemistry, Brazil, Distribution Share by Revenue ($mn), 2007-2008 48
Table 15: Clinical Chemistry, Brazil, Company Share by Revenue ($ mn), 2007-2008 49
Table 16: Genetic Testing, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 50
Table 17: Genetic Testing, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 51
Table 18: Genetic Testing, Brazil, Distribution Share by Revenue ($mn), 2007-2008 52
Table 19: Genetic Testing, Brazil, Company Share by Revenue ($ mn), 2007-2008 53
Table 20: Haematology, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 55
Table 21: Haematology, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 57
Table 22: Haematology Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 58
Table 23: Haematology Reagents, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 59
Table 24: Immunohaematology, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 60
Table 25: Immunohaematology, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 61
Table 26: Haemostasis, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 63
Table 27: Haemostasis, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 65
Table 28: Haematology Rapid Tests, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 66
Table 29: Haematology Rapid Tests, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 67
Table 30: Haematology Cell Counters, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 68
Table 31: Haematology Cell Counters, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 69
Table 32: Haematology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 70
Table 33: Haematology, Brazil, Company Share by Revenue ($ mn), 2007-2008 71
Table 34: Histology And Cytology, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 72
Table 35: Histology And Cytology, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 73
Table 36: Histology, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 74
Table 37: Histology, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 75
Table 38: Histology And Cytology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 76
Table 39: Histology And Cytology, Brazil, Company Share by Revenue ($ mn), 2007-2008 77
Table 40: Immuno Chemistry, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 79
Table 41: Immuno Chemistry, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 81
Table 42: Disease Specific Immunochemistry, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 83
Table 43: Disease Specific Immunochemistry, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 85
Table 44: Drug Related Testing, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 86
Table 45: Drug Related Testing, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 87
Table 46: Endocrinology Tests, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 88
Table 47: Endocrinology Tests, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 89
Table 48: Immunochemistry Analyzers, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 91
Table 49: Immunochemistry Analyzers, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 93
Table 50: Immuno Chemistry, Brazil, Distribution Share by Revenue ($mn), 2007-2008 94
Table 51: Immuno Chemistry, Brazil, Company Share by Revenue ($ mn), 2007-2008 96
Table 52: Infectious Immunology, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 98
Table 53: Infectious Immunology, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 100
Table 54: Infectious Immunology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 101
Table 55: Infectious Immunology, Brazil, Company Share by Revenue ($ mn), 2007-2008 103
Table 56: Microbiology Culture, Brazil, Revenue ($ mn) by Segment, Historic, 2000-2008 105
Table 57: Microbiology Culture, Brazil, Revenue ($ mn) by Segment, Forecast, 2008-2015 107
Table 58: Microbiology Analyzers, Brazil, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 108
Table 59: Microbiology Analyzers, Brazil, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 109
Table 60: Microbiology Culture, Brazil, Distribution Share by Revenue ($mn), 2007-2008 110
Table 61: Microbiology Culture, Brazil, Company Share by Revenue ($ mn), 2007-2008 111
Table 62: Sysmex Corporation Pipeline Products by Equipment Type 112
Table 63: Sysmex Corporation Pipeline Products By Development Stage 112
Table 64: Sysmex Corporation Pipeline Products By Therapy Area 113
Table 65: Sysmex Corporation Pipeline Products By News Summary 113
Table 66: Qiagen N.V. Pipeline Products by Equipment Type 115
Table 67: Qiagen N.V. Pipeline Products By Development Stage 115
Table 68: Qiagen N.V. Pipeline Products By Therapy Area 116
Table 69: Qiagen N.V. Pipeline Products By News Summary 116
Table 70: Phadia AB Pipeline Products by Equipment Type 117
Table 71: Phadia AB Pipeline Products By Development Stage 117
Table 72: Phadia AB Pipeline Products By Therapy Area 118
Table 73: Phadia AB Pipeline Products By News Summary 118
Table 74: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 119
Table 75: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 120
Table 76: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 120
Table 77: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 122
Table 78: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 122
Table 79: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 123
Table 80: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 123
Table 81: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 123
Table 82: Hologic, Inc. Pipeline Products by Equipment Type 124
Table 83: Hologic, Inc. Pipeline Products By Development Stage 125
Table 84: Hologic, Inc. Pipeline Products By Therapy Area 125
Table 85: Hologic, Inc. Pipeline Products By Clinical Trials 125
Table 86: Hologic, Inc. Pipeline Products By News Summary 126
Table 87: Gen-Probe Incorporated Pipeline Products by Equipment Type 127
Table 88: Gen-Probe Incorporated Pipeline Products By Development Stage 128
Table 89: Gen-Probe Incorporated Pipeline Products By Therapy Area 128
Table 90: Gen-Probe Incorporated Pipeline Products By Clinical Trials 128
Table 91: Gen-Probe Incorporated Pipeline Products By News Summary 129
Table 92: DiaSorin S.p.A Pipeline Products by Equipment Type 131
Table 93: DiaSorin S.p.A Pipeline Products By Development Stage 131
Table 94: DiaSorin S.p.A Pipeline Products By Therapy Area 131
Table 95: Becton, Dickinson and Company Pipeline Products by Equipment Type 134
Table 96: Becton, Dickinson and Company Pipeline Products By Development Stage 135
Table 97: Becton, Dickinson and Company Pipeline Products By Therapy Area 135
Table 98: Becton, Dickinson and Company Pipeline Products By Clinical Trials 136
Table 99: Becton, Dickinson and Company Pipeline Products By News Summary 136
Table 100: Beckman Coulter, Inc. Pipeline Products by Equipment Type 137
Table 101: Beckman Coulter, Inc. Pipeline Products By Development Stage 139
Table 102: Beckman Coulter, Inc. Pipeline Products By Therapy Area 140
Table 103: Beckman Coulter, Inc. Pipeline Products By News Summary 140
Table 104: Abbott Laboratories Pipeline Products by Equipment Type 141
Table 105: Abbott Laboratories Pipeline Products By Development Stage 141
Table 106: Abbott Laboratories Pipeline Products By Therapy Area 141
Table 107: Caio Auriemo Completes Sale Of Stake In Diagnosticos da America 142
Table 108: FIR Capital Partners Sells Stake In Prodimol Biotecnologia To Orgenics 143
Table 109: Chembio Signs An Agreement With Oswaldo Cruz Foundation 144
Table 110: USD to Local Currency, Average Exchange Rate 2008 150


Companies Mentioned Ventana Medical Systems, Inc. Sysmex Corporation Siemens Healthcare Qiagen N.V. Phadia AB Ortho-Clinical Diagnostics Inc. OLYMPUS CORPORATION Inverness Medical Innovations, Inc. Hologic, Inc. Gen-Probe Incorporated F. Hoffmann-La Roche Ltd. DiaSorin S.p.A Dade Behring Holdings, Inc. Bio-Rad Laboratories, Inc. bioMerieux S.A. Becton, Dickinson and Company Beckman Coulter, Inc. Abbott Laboratories


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/993000

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 03:24:48
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Brazil In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Web Address:
http://www.researchandmarkets.com/reports/993000
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,911.00
Electronic (PDF) - Site License €3,821.00
Electronic (PDF) - Enterprisewide €5,732.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 03:24:48

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)